SCHEMBL7800909

SCHEMBL7800909

O=C=CC(=O)n1c(=O)[nH]c2nc[nH]c2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 7/20 0.50
ADORA2A P29274 4/20 0.50
ADORA3 P0DMS8 6/20 0.47
PDE4A P27815 3/20 0.47
PDE4B Q07343 3/20 0.47
PDE4C Q08493 3/20 0.47
PDE4D Q08499 3/20 0.47
GDA Q9Y2T3 2/20 0.37
ACHE P22303 1/20 0.37
ABL1 P00519 1/20 0.35
RIN1 Q13671 1/20 0.35
ADORA1 P30542 1/20 0.33
TDP1 Q9NUW8 2/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TP53 P04637 1/20 0.30
HPGD P15428 1/20 0.30
PTGS1 P23219 1/20 0.30
HBB P68871 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7491449 0.83 ADORA2B (0.56) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL3085107 0.79 ADORA2B (0.58) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL8884694 0.78 ADORA2B (0.61) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL6555067 0.78 ADORA2B (0.57) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL28837899 0.71 ADORA2B (0.60) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL618977 0.71 ADORA2B (0.64) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL7491460 0.70 ADORA2B (0.70) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL18285098 0.70 ADORA2A (0.55) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL8952223 0.70 ADORA2A (0.55) ADORA2BADORA2AADORA3PDE4APDE4B
SCHEMBL11572222 0.69 ADORA2B (0.59) ADORA2BADORA2AADORA3PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0811623-B1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AG (DE) 2001-04-04 EP disclosed
US-5965555-A TREATMENT AND/OR PROPHYLAXIS OF CEREBROVASCULAR DISORDERS CHARACTERIZED BY DAMAGE CAUSED BY ISCHEMIA AND SUBSEQUENT NECROTIC DESTRUCTION OF NERVE CELLS(NEURONS) HOECHST AKTIENGESELLSCHAFT (DE) 1999-10-12 US disclosed
EP-0811623-A1 Xanthine derivatives with end-aminated alkynol side chains HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-10 EP disclosed